Supportive care for the patient with Alzheimer's disease.

M. W. Jann, N. Brandt

Research output: Contribution to journalArticle

3 Scopus citations

Abstract

The prevalence of AD, the most common form of dementia, is likely to double in the next 20 years. Although the cause of AD is unknown, risk factors include aging, genetic predisposition, and head trauma. The cholinesterase inhibitors (tacrine, donepezil, and rivastigmine) are the only FDA-approved class of medications for AD. Behavioral problems associated with AD are a major reason for admission to long-term care facilities and a common cause of caregiver "burnout" or stress.

Original languageEnglish
Pages (from-to)S50-51
JournalJournal of the American Pharmaceutical Association (Washington,D.C. : 1996)
Volume40
Issue number5 Suppl 1
DOIs
StatePublished - 2000

Fingerprint Dive into the research topics of 'Supportive care for the patient with Alzheimer's disease.'. Together they form a unique fingerprint.

  • Cite this